(BLX) Foreign Trade Bank of Latin - Overview
Stock: Loans, Guarantees, Leasing, Investments
| Risk 5d forecast | |
|---|---|
| Volatility | 25.8% |
| Relative Tail Risk | -6.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.44 |
| Alpha | 28.26 |
| Character TTM | |
|---|---|
| Beta | 0.593 |
| Beta Downside | 1.141 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.01% |
| CAGR/Max DD | 2.54 |
EPS (Earnings per Share)
Revenue
Description: BLX Foreign Trade Bank of Latin March 04, 2026
BLX, or Banco Latinoamericano de Comercio Exterior, S. A., is a multinational bank specializing in foreign trade finance and economic integration across Latin America and the Caribbean. The bank operates through Commercial and Treasury segments.
Its services include short- and medium-term loans, structured and syndicated credits, and various financial guarantee contracts such as letters of credit. The company also engages in co-financing, underwriting, structured trade financing (e.g., factoring, vendor financing), and financial leasing. These activities are typical for specialized finance institutions, which often focus on niche markets or specific types of transactions rather than broad retail banking.
BLX accepts deposits and manages investments, including securities at fair value and amortized cost. Clients include financial institutions, corporations, sovereigns, and state-owned entities. The bank was founded in 1975 and is headquartered in Panama City, Panama. Understanding the specific risks and opportunities within the Latin American financial sector is crucial for evaluating such an institution. For further detailed analysis, consider exploring ValueRays comprehensive data.
Headlines to watch out for
- Latin American trade finance demand drives loan growth
- Interest rate changes impact net interest margin
- Regional economic stability affects credit quality
- Regulatory compliance costs influence profitability
- Deposit growth supports lending capacity
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 226.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 15.76 > 1.0 |
| NWC/Revenue: 250.4% < 20% (prev -643.4%; Δ 893.9% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.14b > Net Income 226.9m |
| Net Debt (2.26b) to EBITDA (230.0m): 9.81 < 3 |
| Current Ratio: 14.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.3m) vs 12m ago 1.48% < -2% |
| Gross Margin: 44.29% > 18% (prev 0.33%; Δ 4.40k% > 0.5%) |
| Asset Turnover: 5.82% > 50% (prev 6.84%; Δ -1.02% > 0%) |
| Interest Coverage Ratio: 0.34 > 6 (EBITDA TTM 230.0m / Interest Expense TTM 497.3m) |
Altman Z'' 1.44
| A: 0.14 (Total Current Assets 1.93b - Total Current Liabilities 130.5m) / Total Assets 12.79b |
| B: 0.08 (Retained Earnings 1.08b / Total Assets 12.79b) |
| C: 0.01 (EBIT TTM 170.9m / Avg Total Assets 12.32b) |
| D: 0.15 (Book Value of Equity 1.65b / Total Liabilities 11.11b) |
| Altman-Z'' Score: 1.44 = BB |
Beneish M
| DSRI: none (Receivables none/122.2m, Revenue 716.7m/810.6m) |
| GMI: 0.76 (GM 44.29% / 33.50%) |
| AQI: 1.04 (AQ_t 0.85 / AQ_t-1 0.81) |
| SGI: 0.88 (Revenue 716.7m / 810.6m) |
| TATA: -0.07 (NI 226.9m - CFO 1.14b) / TA 12.79b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of BLX shares?
Over the past week, the price has changed by +3.92%, over one month by +3.67%, over three months by +15.95% and over the past year by +41.30%.
Is BLX a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.5 | 10.1% |
| Analysts Target Price | 55.5 | 10.1% |
BLX Fundamental Data Overview March 20, 2026
P/E Forward = 8.3752
P/S = 5.6843
P/B = 1.0911
P/EG = 1.7665
Revenue TTM = 716.7m USD
EBIT TTM = 170.9m USD
EBITDA TTM = 230.0m USD
Long Term Debt = 4.03b USD (from longTermDebt, last quarter)
Short Term Debt = 130.5m USD (from shortTermDebt, last quarter)
Debt = 4.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.26b USD (from netDebt column, last quarter)
Enterprise Value = 3.88b USD (1.63b + Debt 4.18b - CCE 1.93b)
Interest Coverage Ratio = 0.34 (Ebit TTM 170.9m / Interest Expense TTM 497.3m)
EV/FCF = 3.41x (Enterprise Value 3.88b / FCF TTM 1.14b)
FCF Yield = 29.34% (FCF TTM 1.14b / Enterprise Value 3.88b)
FCF Margin = 158.9% (FCF TTM 1.14b / Revenue TTM 716.7m)
Net Margin = 31.66% (Net Income TTM 226.9m / Revenue TTM 716.7m)
Gross Margin = 44.29% ((Revenue TTM 716.7m - Cost of Revenue TTM 399.2m) / Revenue TTM)
Gross Margin QoQ = 93.92% (prev 36.50%)
Tobins Q-Ratio = 0.30 (Enterprise Value 3.88b / Total Assets 12.79b)
Interest Expense / Debt = 2.88% (Interest Expense 120.2m / Debt 4.18b)
Taxrate = 21.0% (US default 21%)
NOPAT = 135.0m (EBIT 170.9m * (1 - 21.00%))
Current Ratio = 14.75 (Total Current Assets 1.93b / Total Current Liabilities 130.5m)
Debt / Equity = 2.49 (Debt 4.18b / totalStockholderEquity, last quarter 1.68b)
Debt / EBITDA = 9.81 (Net Debt 2.26b / EBITDA 230.0m)
Debt / FCF = 1.98 (Net Debt 2.26b / FCF TTM 1.14b)
Total Stockholder Equity = 1.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.84% (Net Income 226.9m / Total Assets 12.79b)
RoE = 14.85% (Net Income TTM 226.9m / Total Stockholder Equity 1.53b)
RoCE = 3.07% (EBIT 170.9m / Capital Employed (Equity 1.53b + L.T.Debt 4.03b))
RoIC = 2.59% (NOPAT 135.0m / Invested Capital 5.20b)
WACC = 3.90% (E(1.63b)/V(5.81b) * Re(8.07%) + D(4.18b)/V(5.81b) * Rd(2.88%) * (1-Tc(0.21)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.08%
[DCF] Terminal Value 80.82% ; FCFF base≈1.14b ; Y1≈747.7m ; Y5≈341.9m
[DCF] Fair Price = 299.2 (EV 10.85b - Net Debt 2.26b = Equity 8.60b / Shares 28.7m; r=6.0% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 84.68 | EPS CAGR: 52.37% | SUE: 3.23 | # QB: 6
Revenue Correlation: 63.02 | Revenue CAGR: 23.34% | SUE: 0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=6.67 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+7.6% | Growth Revenue=+6.6%